Xtx Topco LTD Viracta Therapeutics, Inc. Transaction History
Xtx Topco LTD
- $1.81 Billion
- Q1 2025
A detailed history of Xtx Topco LTD transactions in Viracta Therapeutics, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 93,391 shares of VIRX stock, worth $1,867. This represents 0.0% of its overall portfolio holdings.
Number of Shares
93,391
Previous 14,809
530.64%
Holding current value
$1,867
Previous $2,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding VIRX
# of Institutions
21Shares Held
2.3MCall Options Held
1.8KPut Options Held
0-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.63MShares$32,5250.0% of portfolio
-
Black Rock Inc. New York, NY273KShares$5,4650.0% of portfolio
-
Hrt Financial LP New York, NY82.7KShares$1,6530.0% of portfolio
-
State Street Corp Boston, MA65.9KShares$1,3170.0% of portfolio
-
United Capital Financial Advisers, LLC Newport Beach, CA43KShares$8590.0% of portfolio
About Viracta Therapeutics, Inc.
- Ticker VIRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 37,558,200
- Market Cap $751K
- Description
- Viracta Therapeutics, Inc., a precision oncology company, engages in developing drugs for the treatment of virus-associated malignancies. Its lead product candidature includes Nana-val, in combination with nanatinostat and valganciclovir that is in Phase II clinical trial for Epstein-Barr virus-positive lymphoma; and open-label Phase 2 basket tr...